Pharmoduct: The optimal balance of batch efficiency and patient-centric dose compounding.
Pharmoduct is a new-generation robot that automates the sterile compounding of oncology medications. It is a patented medical device in the EU, and it respects all the regulatory requirements of a laminar flow hood.
Inside its ISO 4.8 main chamber, it can reconstitute powders and dilute solutions in a wide range of final containers, including Elastomeric Pumps. Pharmoduct can integrate with medication prescribing and dispensing systems for optimal ordering, auditing, and scheduling.
Pharmoduct is designed to improve the whole oncology compounding process.
Why Pharmoduct?
The recent rise in cancer cases comes with the ever-increasing need for compounded oncology medications. Today, pharmacies struggle to meet the increasing demand for compounded medications with the manual process. Pharmoduct brings efficiencies, quality, and safety to a higher level, which manual compounding does not provide. It compounds up to 20 preparations per hour with an error rate of less than 5%. In one session, it can compound in a range of final containers. Pharmoduct helps organisations disrupt the growing staffing issues associated with 8-12% annual growth in compounding preparations. Its reliance on closed-system drug transfer devices ensures staff and patient safety.
Key Features and Benefits
- Optimises staff availability & reduce the effect of fatigue on productivity
- Higher product accuracy & better patient safety
- Small footprint for higher compounding volumes
- Full process traceability
- Almost eliminates scheduling & transcription errors by automatically receiving and sending messages from and to other systems
Bringing Benefits and Features to Oncology Compounding
Pharmoduct automates the compounding process to overcome many manual compounding challenges.
CONTACT US
Book a product demo or speak to one of our specialists.
"'*' indicates required fields"*" indicates required fields